CELL PROLIFERAT 润色咨询

CELL PROLIFERATION

出版年份:1991 年文章数:930 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:6.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-07-18 meww 来自江苏省

    审稿速度:3.0
    偏重的研究方向:发育;口腔
    经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-12-18 ms3000001788822144 来自上海

    细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。
    该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭
    看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2020-05-21 txsyzu_32760595

    4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?jack123123 2020-05-18 发表::
    现在很难投了,好多不送审直接毙掉 哎
    jack123123 2020-05-18 00:00:00 发表:
    现在很难投了,好多不送审直接毙掉 哎

    jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-07-27 ms1000000907051820 来自河南

    请问系统出现ADM:…, under review是送审了吗?

    8

    展开8条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-08-08 ms5000001215794688 来自北京

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:药物递送
    经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-08-16 ms5000001191279198 来自北京

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:干细胞;再生;发育
    经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-08-23 ms7000000339495981 来自北京

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:代谢;干细胞;再生
    经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-08-16 ms5000001191279198 来自北京

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:干细胞;再生;发育
    经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-08-13 ms8000001022390356 来自北京

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤;单细胞;类器官
    经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0<br>偏重的研究方向:发育;口腔<br>经验分享:刚投稿就变成Under review,此状态持续了8周。写信问编辑,编辑回复审稿人意见已经收齐,此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243409, encodeId=7bcb22434090b, content=细胞增殖和分化相关的研究,包括干细胞、再生医学、组织工程、细胞周期控制、细胞衰老等领域内容比较适合。<br>该说不说,拒稿速度很快,别问我怎么知道了,刚亲身经历过😭<br>看评论区大家分享的感觉进度感觉审稿周期差不多在2-3个月左右。其他的我也不知道了,大家有知道可以继续跟一跟😉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 22:56:51 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交,5月20日awaiting EIC decision, 是不是被拒的可能很大?或者其他人有这情况?<span class="quote">jack123123 2020-05-18 发表::<br>现在很难投了,好多不送审直接毙掉 哎</span><span class="quote">jack123123 2020-05-18 00:00:00 发表:<br>现在很难投了,好多不送审直接毙掉 哎</span>, beContent=jack123123 2020-05-18 发表:: 现在很难投了,好多不送审直接毙掉 哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药物递送<br>经验分享:效率挺高的,2个多月给了小修,reviewer中只有一个比较难搞,要求补了不少。编辑回复很专业迅速,也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:审稿速度快,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢;干细胞;再生<br>经验分享:非常好的期刊!编辑和审稿人都特别负责,送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;再生;发育<br>经验分享:投稿周期短,编辑和审稿人给的意见都很专业。国产期刊之光!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;单细胞;类器官<br>经验分享:总体投稿经历较波折,修回了很多实验,不过幸好最终收到了好的结果!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;类器官;代谢<br>经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京)]
    2024-08-12 ms3000000226534790 来自北京

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;类器官;代谢
    经验分享:刚接收一篇,感觉编委和审稿人都挺专业的,有些黑子是被拒稿了心里不平衡吧?

    0

共462条页码: 1/47页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分